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Abstract
Ten new bis-spirolabdane diterpenoids, leonepetaefolins A–E (1, 3, 5, 7, 9) and 15-epi-
leonepetaefolins A-E (2, 4, 6, 8, 10), together with eight known labdane diterpenoids (11–18) as
well as two known flavonoids apigenin and cirsiliol, were isolated from the leaves of Leonotis
nepetaefolia. The structures of the new compounds were determined on the basis of 1D-and 2D-
NMR experiments including 1H, 13C, DEPT, 1H-1H COSY, HSQC, HMBC, and NOESY. The
absolute configuration of an epimeric mixture of 1 and 2 was determined by X-ray
crystallographic analysis. The compounds isolated were evaluated for their binding propensity in
several CNS G protein-coupled receptor assays in vitro.
Leonotis nepetaefolia R. Br. (family: Lamiaceae, syn. Labiatae), also known as Klip Dagga
or Lion's Ear, is widely distributed throughout tropical Africa, southern India, and the
tropical regions of America. It is traditionally used in Caribbean folk medicine and
Ayurvedic herbal medicine to treat a wide array of human diseases such as coughs, fever,
stomachache, skin infections, rheumatism, dysmenorrhea, and kidney dysfunction.1–4 In
Mexico, the name “mota”(marijuana) is given for this plant, which suggests that L.
nepetaefolia is used as a marijuana substitute.5 In addition, a variety of biological activities
including antispasmodic,5 antibacterial, antifungal,6,7 anti-inflammatory,8 antioxidative,9,10
antiasthmatic, and antidiarrheal11 activities have been reported for the crude extracts or pure
compounds from this plant. Previous phytochemical studies of the plant indicated the
presence of labdane diterpenoids,2,4,12–17 iridoids,9,10 and coumarins.18 As part of an
ongoing effort to search for bioactive constituents from psychoactive plants, the lipid extract
of the leaves of L. nepetaefolia was investigated. This procedure led to the isolation of ten
new bis-spirolabdane diterpenoids, named leonepetaefolins A–E (1, 3, 5, 7, 9) and 15-epi-
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leonepetaefolins A–E (2, 4, 6, 8, 10), together with eight known labdane diterpenoids
including methoxynepataefolin (11),13,16,19 nepetaefolin (12),12,15,20 nepetaefuran (13),12
dubiin (14),21 compound 15,12 leonotinin (16),14,20 leonotin (17),20 and LS-1 (18),22 and
two known flavonoids apigenin23 and cirsiliol.24 Herein, we describe the isolation and
structural elucidation of the ten new bis-spirolabdane diterpenoids 1–10.
RESULTS AND DISCUSSION
The dried CH2Cl2-MeOH (1:1) extract of the leaves of L. nepetaefolia was dissolved in 90%
aq. MeOH, and partitioned with hexanes and CH2Cl2, successively. The CH2Cl2-soluble
portion was subjected repeatedly to silica gel, Sephadex LH-20, and Lichroprep RP-18 gel
column chromatography (CC), and semi-preparative HPLC, to afford ten new bis-
spirolabdane diterpenoids 1–10, eight known labdane diterpenoids 11–18, and two known
flavonoids.
Leonepetaefolin A (1) and 15-epi-leonepetaefolin A (2) were obtained as colorless plates,
, in a 1:1 epimeric mixture. Their positive-ion HRESIMS gave a pseudomolecular
peak at m/z 445.1847 [M + Na]+, consistent with the molecular formula of C22H30O8,
indicating eight degrees of unsaturation. In the IR spectrum, absorption bands of hydroxy
(3511 cm−1) and two ester (1735, 1712 cm−1) functional groups were observed. The 13C
NMR and DEPT spectra of 1/2 showed 22 pairs of carbon signals including two pairs of
ester carbonyl carbons (δC 170.3/170.4, 176.0/175.8), five pairs of quaternary sp3 carbons
(δC 40.9/40.8, 41.0 × 2, 55.9/56.0, 86.2/87.2, 90.2/89.7), three pairs of sp3 methines (δC
47.0/47.2, 67.7/67.9, 98.5/98.8), ten pairs of sp3 methylenes (δC 20.2/20.3, 23.2/23.5, 32.4 ×
2, 33.2/33.5, 36.1/35.1, 39.5/39.6, 45.6/47.0, 47.4/47.3, 73.7/73.9, 77.5/78.1), and two pairs
of methyls (δC 20.9 × 2, 22.2/22.1). Analysis of the 1D- and 2D-NMR spectra revealed that
compounds 1/2 belong to the bis-spirolabdane class of diterpenoids, which possess a
spirotetrahydrofuran ring system.25–31 An exocyclic epoxide ring [δH 2.28 (1H, d, J = 3.2
Hz)/2.31(1H, d, J = 2.4 Hz), 2.53 (1H, m)/ 2.53 (1H, m); δC 47.4/47.3 (C-17), 55.9/56.0
(C-8)] was indicated by the HSQC and HMBC (H2-17/C-8) correlations. This epoxide ring
was placed at C-8 on the basis of its high-field chemical shift (δC 55.9/56.0) and the HMBC
correlations between H2-17 [δH 2.28 (1H, d, J = 3.2 Hz)/2.31(1H, d, J = 2.4 Hz), 2.53 (1H,
m)/ 2.53 (1H, m)] and C-7 (δC 32.4), C-8 (δC 55.9/56.0), C-9 (δC 86.2/87.2). In the HMBC
spectrum, the presence of cross peaks between H-6 (δH 5.12, br s) and the acetoxy carbonyl
carbons (δC 170.3/170.4) indicated that an acetoxy group is connected to C-6, which was
also supported by the downfield chemical shift of H-6. In view of the eight degrees of
unsaturation, there must be an additional ring in the structures of 1/2. The observation of
HMBC correlations between H2-20 [δH 3.94 (2H, d, J = 11.6 Hz), 5.01 (2H, d, J = 11.6 Hz)]
and carbonyl carbons C-19 (δC 176.0/175.8) suggested that a δ-lactone ring was present
between C-19 and C-20. Comparison of 1H and 13C NMR data (Tables 1 and 2) with the
literature values for methoxynepataefolin (11) revealed that the structures of 1/2 are similar
to that of 11,19 except that the C-15 O-methyl group in 11 was replaced by a hydroxy group
in 1/2. This was supported by the significant upfield shift at C-15 (δC 98.5/98.8; WδC –
6.1/5.8). Furthermore, the HMBC correlations between H3-18 and C-19, H2-16 and C-12/
C-15, H-15 and C-13/C-16, H2-14 and C-12/C-16, H2-11 and C-8/C-10/C-13, H2-20 and
C-1/C-9, H-6 and C-4/C-5/C-8/C-10 also supported the proposed planar structures of 1/2
(Figure 1). The relative configurations at C-4, -5, -6, -8, -9, -10, -13 of 1/2 are the same as
those of methoxynepataefolin (11) on the basis of NOESY data (Figure 1). The orientations
of the C-15 hydroxy group were assigned as β in 1 and α in 2 based on the absence/presence
of NOE correlation between H-15 and H2-12. The absolute configurations of 1/2 were
defined as 4S, 5R, 6R, 8R, 9S, 10S, 13R and 15S/R by single-crystal X-ray diffraction
analysis (Figure 2). Therefore, the structures of 1/2 were determined to be (4S, 5R, 6R, 8R,
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9S, 10S, 13R, 15S/R)-6-acetoxy-8,17;9,13;15,16-triepoxy-15-hydroxylabdan-19,20-olide,
named leonepetaefolin A (1) and 15-epi-leonepetaefolin A (2).
A 2:3 epimeric mixture of leonepetaefolin B (3) and 15-epi-leonepetaefolin B (4) was
obtained as colorless gum, . Their positive-ion HRESIMS showed a
pseudomolecular ion peak at m/z 389.1934 [M + Na]+ and established a molecular formula
of C20H30O6, implying six degrees of unsaturation. The IR spectrum of 3/4 indicated the
presence of hydroxy (3400 cm−1) and lactone (1747 cm−1) groups. The 1H and 13C NMR
spectra (Tables 1 and 2) exhibited duplicate resonances of three tertiary methyl groups (δH
0.98/0.99, 1.25×2, 1.27/1.30; δC 21.0/21.1, 25.9/26.0, 31.7/31.9, respectively), a hemiacetal
methine carbon (δC 98.3/98.5), three oxygenated quaternary carbons (δC 92.6/93.7,
88.8/89.2, 75.4×2), an isolated oxygenated methylene (δH 3.80/4.04, 3.76/3.52; δC
76.8/75.8), an oxygenated methine (δH 4.79×2; δC 74.4/74.3), seven methylenes (δC
45.3/44.5, 41.0×2, 38.0/36.2, 32.3/32.4, 29.3/29.2, 28.5/28.2, 17.7×2), one methine (δH
2.08/2.04; δC 45.3/45.5), two quaternary carbons (δC 42.0×2, 39.6/39.7) and an ester
carbonyl carbon (δC 182.1/182.2). These spectroscopic data suggested that compounds 3/4
are bis-spirolabdane diterpenoids possessing a spirotetrahydrofuran ring system.25–31 On the
basis of the six degrees of unsaturation, there must be an extra ring in the structures of 3/4.
The downfield chemical shift of H-6 (δH 4.79) suggested that the C-6 hydroxy group was
acylated, and therefore a γ-lactone ring between C-6 and C-19 was proposed. The 1H
and 13C NMR data of 3/4 were comparable to those of cyllenin A/15-epi-cyllenin A, which
were isolated from Marrubium cylleneum27 and M. globosum ssp. libanoticum,29 except for
the significant downfield shift at C-7 (δC 41.0×2; WδC + 9.3), C-8 (δC 75.4×2; WδC +
43.6), and C-17 (δC 31.7/31.9; WδC + 14.5). This is in agreement with the addition of an
extra hydroxy group at C-8 in 3/4, which was supported also by the observation of methyl
singlets instead of methyl doublets for H3-17 in the 1H NMR spectrum. The proposed planar
structures of 3/4 were confirmed by the HMBC correlations between H3-20 and C-1/C-5/
C-9, H3-18 and C-19, H3-17 and C-7/C-8/C-9, H2-16 and C-12/C-15, H-15 and C-13/C-14/
C-16, H2-14 and C-12/C-16, H2-11 and C-8/C-10/C-13, H-6 and C-7/C-8/C-10 (Figure 3).
The NOESY experiment permitted assignment of the relative configurations of 3/4. In the
NOESY spectrum, the absence of NOE correlations between H3-20 and H-5 supported the
trans fusion of rings A and B in 3/4. NOEs between H-5/H-6, H-5/H-1a, H-5/ H3-18, H-6/
H3-18 indicated that they are cofacial and α-oriented, while NOE cross-peaks between
H3-20/ H-1b, H3-20/ H2-11 suggested that these protons occupy the opposite side and are
thus β-oriented. The NOE correlations between H-1a/H2-16 as well as H2-14/H3-17
suggested the relative configuration at C-13 as shown in 3/4 (Figure 4). This observation
also proved the α-orientation of Me-17. Furthermore, a NOE correlation between H-15 and
H2-12 suggested the α-orientation of the C-15 hydroxy group in 4, while the absence of an
NOE between H-15 and H2-12 indicated OH-15 to be β-oriented in 3. Thus, the structures of
leonepetaefolin B and 15-epi-leonepetaefolin B were proposed as shown in 3/4.
Leonepetaefolin C (5) and 15-epi-leonepetaefolin C (6) were obtained as an inseparable
epimeric mixture (1:1), . The IR spectrum exhibited absorption bands for hydroxy
(3408 cm−1) and lactone (1747 cm−1) groups. The molecular formula, C20H30O6, of 5/6 was
determined to be same as that of 3/4 by positive-ion HRESIMS (m/z 389.1934 [M + Na]+).
Slight differences in 1H and 13C NMR spectroscopic data (Tables 1 and 2) of 5/6 in
comparison with those of 3/4 suggested that they could be stereoisomeric compounds. 2D
NMR experiments including 1H-1H COSY, HSQC, and HMBC facilitated the assembly of
the planar structures of 5/6, as the same as those of 3/4. The relative configurations at C-4,
-5, -6, -8, -9, -10 were the same as assigned in 3/4 on the basis of NOESY data (Figure 4).
The observation of NOE correlations between H-1a/H2-14 as well as H2-16/H3-17 indicated
that compounds 5/6 have the opposite configuration at C-13 compared to that of 3/4. The
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C-15 hydroxy group was proved to be α-oriented in 6 on the basis of an NOE correlation
between H-15 and H2-12, while no such NOE was observed in 5, suggesting its OH-15
group to be β-oriented. Accordingly, the structures of leonepetaefolin C and 15-epi-
leonepetaefolin C were elucidated as shown in 5/6.
An inseparable 7:10 epimeric mixture of leonepetaefolin D (7) and 15-epi-leonepetaefolin D
(8) was obtained as a colorless gum, . The positive-ion HRESIMS of 7/8
exhibited a pseudomolecular ion at m/z 387.1778 [M + Na]+, which is consistent with a
molecular formula of C20H28O6, indicating seven degrees of unsaturation. IR absorptions
revealed the presence of hydroxy (3424 cm−1) and lactone (1764 cm−1) groups. The 1H
and 13C NMR spectra of 7/8 demonstrated two sets of signals, which were distinguishable
according to their relative abundance. The close structural similarities between 7/8 and 3/4
were evident from their 1H and 13C NMR spectroscopic data (Tables 1 and 2), except for the
significant upfield shifts of C-7 (δC 32.5/32.4; WδC – 8.5/8.6), C-9 (δC 88.8/90.0; WδC –
3.8/3.7), and C-8 (δC 56.7; WδC – 18.7), and significant downfield shift of C-17 (δC
48.8/49.0; WδC + 17.1). These data, coupled with the seven degrees of unsaturation of 7/8
(one more degree of unsaturation than 3/4), suggested the presence of an exocyclic epoxide
ring at C-8 in 7/8, which was supported by the HMBC correlations between H2-17 and C-7/
C-8/C-9. The HMBC correlations shown in Figure 3 confirmed the planar structures of 7/8.
The relative configurations of C-4, -5, -6, -8, -9, -10, -13 of 7/8 were found to be same as
those of 3/4 based on the NOESY data (Figure 4). In particular, NOE correlations between
H2-14/H2-17 suggested the relative configurations of C-13 and the epoxide ring as shown in
7/8 (Figure 4). Furthermore, the α-orientation of the C-15 hydroxy group in 8 was deduced
from the NOE correlation between H-15 and H2-12, while the absence of a NOE correlation
between H-15 and H2-12 indicated the β-orientation of OH-15 in 7. Thus, the structures of
leonepetaefolin D and 15-epi-leonepetaefolin D were established as shown in 7/8.
Leonepetaefolin E (9) and 15-epi-leonepetaefolin E (10) were obtained as an inseparable
epimeric mixture (2:3), , and have the same molecular formula (C20H28O6) as
those of 7/8, as indicated by the positive-ion HRESIMS (m/z 387.1788 [M + Na]+). From
the IR spectrum, hydroxy (3415 cm−1) and lactone (1765 cm−1) groups were evident. The
resemblance of the 1H and 13C NMR data (Tables 1 and 2) of 9/10 and 7/8 suggested the
stereoisomeric nature of these compounds. The molecular structures of 9/10 were similar to
those of 7/8 on the basis of 2D-NMR experiments including 1H-1H COSY, HSQC, and
HMBC. The relative configurations at C-4, -5, -6, -8, -9, -10 were assigned as being the
same as those of 7/8, which were deduced by a NOESY experiment (Figure 4). Diagnostic
NOE correlations between H-1a/H2-14 as well as H2-16/H2-17 demonstrated the opposite
configurations at C-13 in 9/10 and 7/8. As for 7/8, the absence/presence of NOE correlation
between H-15 and H2-12 permitted assignment of the orientation of OH-15 to be β in 9 and
α in 10. Therefore, the structures of leonepetaefolin E and 15-epi-leonepetaefolin E were
determined as shown in 9 and 10.
By comparing spectroscopic and specific rotation data with literature values, the ten known
compounds isolated in this investigation were identified as methoxynepataefolin (11),13,16,19
nepetaefolin (12),12,15,20 nepetaefuran (13),12 dubiin (14),21 compound 15,12 leonotinin
(16),14,20 leonotin (17),20 LS-1 (18),22 apigenin,23 and cirsiliol.24 It is worth noting that
compound 15 is a chlorinated derivative of nepetaefuran (13). This compound was
previously obtained by reacting nepetaefolin (12) or nepetaefuran (13) with phosphorus
oxychloride via an SNi addition mechanism.12 Naturally occurring chlorinated compounds
derived from higher plants are rare, consistent with the difficulty of explaining a chlorine
source for the biosynthesis of chlorinated compounds in these organisms. In order to test
whether compound 15 was obtained an isolation artifact, a crude methanol extract of L.
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nepetaefolia was analyzed by LC-MS. The result showed that compound 15 could not be
detected in this crude extract. Furthermore, nepetaefuran (13) was found to be readily
converted into 15 in the presence of HCl. Dichloromethane was used as extraction and
partition solvent during the isolation procedure. It is known that dichloromethane contains
trace amounts of HCl, especially when stored for a long time and exposed to light. Thus, it is
most likely that the chlorinated compound 15 could be an artifact. A similar phenomenon
was encountered during the chemical investigation of black cohosh, Cimicifuga racemosa.32
The isolated compounds (1–20) were evaluated for their binding activities to a panel of CNS
G-protein-coupled receptors including adrenergic, dopaminergic, histaminic, muscarinic,
opioid, serotonergic receptors, and neurotransmitter transporters as previously described.33
In the primary binding assay, leonepetaefolin D and 15-epi-leonepetaefolin D (7/8) at 10 µM
inhibited 3H]SCH23390 binding to the human dopaminergic D5 receptor (hD5R) as well as
[3H]QNB binding to the human muscarinic M3 receptor (hM3R) by more than 50%.
Leonotinin (16) was active on the histaminic H2 receptor (hH2R) (>50% inhibition at 10
µM) and methoxynepataefolin (11) at 10 µM also showed more than 50% inhibition of
[3H]QNB binding to hM3R (Supporting Information). A secondary binding experiment was
performed with several concentrations of these active compounds to determine their Ki
values (binding affinities) for hD5R, hH2R, and hM3R. The Ki values of these compounds




Melting points were measured on OptiMelt MPA100 automated melting point system and
are uncorrected. Optical rotations were obtained on an AP IV/589-546 digital polarimeter. A
PerkinElmer 100 FT-IR spectrometer was used to obtain the IR spectra. The NMR spectra
were recorded on an AMX-NMR spectrometer (Bruker) operating at 400 MHz for 1H and
100 MHz for 13C, respectively. The HRESIMS spectra were determined on a Bruker
Daltonic micro-TOF instrument fitted with an Agilent 1100 series HPLC and an ESI source.
X-ray data were collected using a Bruker Kappa APEX-II diffractometer with CuKα
radiation. HPLC was performed on a Waters Delta Prep 4000 system (Waters Corporation,
Milford, MA), equipped with a 600 controller and a dual wavelength detector model 2487
monitoring at 210 and 198 nm. Two semi-preparative HPLC columns were employed for
isolation: column A, Phenomenex Luna 5 µm, C8, 100 Å, 250 × 10.0 mm; column B,
Phenomenex Synergi 4 µm Fusion-RP C18, 80 Å, 150 × 10.0 mm. Silica gel 60 (63 – 200
µm, Sorbent Technologies, Atlanta, GA, United States), LiChroprep RP-18 gel (40 – 63 µm,
Merck, Germany) and Sephadex LH-20 (Pharmacia) were used for open column
chromatography. TLC was performed using Merck Si60F254 plates, sprayed with
anisaldehyde reagent solution (prepared by mixing 0.5 mL of anisaldehyde with 10 mL of
glacial HOAc, 85 mL of MeOH, and 5 mL of conc. H2SO4) and heated with a heat gun.
Plant Material
The ruderal Leonotis nepetaefolia is one of only two pantropical and commonly cultivated
species of the genus.34 Plant material of L. nepetaefolia was purchased from IAmShaman
Shop, P.O. Box 12618, Chicago, IL 60612, in April 2010 and authenticated by one of the
co-authors(Charles Burandt Jr.). The seller provided information that this material was
cultivated in Peru. The material was predominantly leaves with a few young stems. A
voucher specimen (JLI-LN-201004) is deposited at Department of Pharmacognosy, School
of Pharmacy, University of Mississippi.
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The dried powdered leaves of L. nepetaefolia (400 g) were extracted with CH2Cl2-MeOH
(1:1) by percolation at room temperature. After filtration and evaporation, the residue (52 g)
was dissolved in 90% aq. MeOH and partitioned with hexanes and CH2Cl2, successively.
The dried CH2Cl2 residue (15 g) was subjected to VLC on silica gel eluting with hexanes-
EtOAc solvent system with increasing polarity to yield 11 fractions (A–K). Fractions D and
E (2.7 g) were combined and chromatographed over Sephadex LH-20 and silica gel open
columns, and further purified by repeated semi-preparative HPLC (column A, eluting with
isocratic 57% aq. MeOH) to produce 14 (9.2 mg), 15 (21 mg), 17 (55 mg), and 18 (3.0 mg).
Fraction F (1.0 g) was subjected to Sephadex LH-20 CC to give seven subfractions F1-F7.
Subfraction F4 (370 mg) was chromatographed over a silica gel open column and further
purified by semi-preparative HPLC (column A, eluting with isocratic 60% aq. MeOH) to
yield 12 (11 mg), 13 (54 mg), and 16 (35 mg). Subfraction F6 (10 mg) was washed with
MeOH to afford pure apigenin (3 mg). Fractions I and J (2.4 g) were combined and
precipitated with MeOH to give pure cirsiliol (7.2 mg). The supernatant was subjected to
silica gel open column CC to produce an inseparable mixture of 1/2 (42 mg), 11 (7.5 mg),
and subfractions I1-I7. Subfraction I3 (420 mg) was subjected to RP-18 gel open column CC
(eluting with isocratic 40% aq. MeOH) and repeated semi-preparative HPLC (column B,
eluting with 22% aq.MeCN) to afford inseparable mixtures of 3/4 (10 mg), 5/6 (21 mg), 7/8
(15 mg), and 9/10 (3.0 mg).
Leonepetaefolin A (1)/15-epi-leonepetaefolin A (2)
colorless plates (MeOH), mp 218–224 °C,  (c 0.11, MeOH); IR (film) νmax 3511,
2964, 2935, 1735, 1712, 1242, 1149, 1027, 977, 877 cm−1; 1H and 13C NMR data, see
Tables 1 and 2; positive-ion HRESIMS m/z 445.1847 [M + Na]+ (calcd for C22H30O8,
445.1838).
Leonepetaefolin B (3)/15-epi-leonepetaefolin B (4)
colorless gum, (c 0.08, MeOH); IR (film) νmax 3400, 2933, 1747, 1204, 1142, 989,
923 cm−1; 1H and 13C NMR data see Tables 1 and 2; positive-ion HRESIMS m/z 389.1934
[M + Na]+ (calcd for C20H30O6Na, 389.1940).
Leonepetaefolin C (5)/15-epi-leonepetaefolin C (6)
colorless gum,  (c 0.08, MeOH); IR (film) νmax 3408, 2935, 1747, 1205, 1142,
988, 923 cm−1; 1H and 13C NMR data, see Tables 1 and 2; positive-ion HRESIMS m/z
389.1934 [M + Na]+ (calcd for C20H30O6Na, 389.1940).
Leonepetaefolin D (7)/15-epi-leonepetaefolin D (8)
colorless gum,  (c 0.11, MeOH); IR (film) νmax 3424, 2946, 1764, 1197, 1115,
1003, 924 cm−1; 1H and 13C NMR data, see Tables 1 and 2; positive-ion HRESIMS m/z
387.1778 [M + Na]+ (calcd for C20H28O6Na, 387.1784).
Leonepetaefolin E (9)/15-epi-leonepetaefolin E (10)
colorless gum,  (c 0.18, MeOH); IR (film) νmax 3415, 2946, 1765, 1197,1115,
1003, 925 cm−1; 1H NMR and 13C NMR data, see Tables 1 and 2; positive-ion HRESIMS
m/z 387.1788 [M + Na]+ (calcd for C20H28O6Na, 387.1784).
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X-ray Crystallography of 1 and 2
The crystal structure and absolute configuration of a disordered co-crystal of 1 and 2 was
determined, using data collected at T = 90 K with CuKα radiation (λ = 1.54178 A) on a
Bruker APEX-II CCD diffractometer, equipped with an Oxford Cryostream cooler.
Structures were solved using the program SHELXS-9735 and refined anisotropically by full-
matrix least squares on F2 using SHELXL-97.35 All H atoms were visible in difference
maps, but were placed in idealized positions for the refinements, with torsional parameters
refined for all OH and methyl groups. There are two independent molecules in the
asymmetric unit, and both have substitutional disorder at C-15, with both α- and β-OH
groups present. For each independent molecule, a population parameter was refined,
constraining the the populations of the two epimers to sum to unity. One of the independent
molecules is 72.6% R, while the other is 41.3% R at C-15; overall, the crystal studied was
57.0% R. This may differ from the composition of the bulk sample. The absolute
configuration was determined by refinement of the Flack parameter36 based on resonant
scattering of the light atoms and computation of the Hooft parameter,37 yielding a
probability of 1.000 that the reported configuration is correct. Crystal data: 1/2,
leonepetaefolin A / 15-epi-leonepetaefolin A, C22H30O8, Mr = 422.46, monoclinic space
group P21, a = 10.8606(5), b = 11.4963(5), c = 15.4999(7) A, β = 90.154(2)°, V =
1935.26(15) A3, Z = 4, Dx = 1.450 Mg m−3, θmax = 69.6°, R = 0.029 for 6869 data having
I>2σ(I), wR2=0.077, and GOF=1.041 for all 6922 data, and 571 refined parameters. The
Flack parameter is 0.07(9) and the Hooft parameter is 0.08(4) for 3180 Bijvoet pairs.
It should be noted that the two independent molecules are very nearly related by a 21 screw
axis orthogonal to the monoclinic symmetry direction. Thus, there is a strong
pseudosymmetry, closely resembling orthorhomic P212121. The structure can be refined in
P212121 to nearly the same R value, 0.031. However, this model requires only one
independent molecule with a single R/S ratio and a β- angle symmetry-constrained to
exactly 90°. However, averaging the intensity data under orthorhombic symmetry yields Rint
= 0.059 vs. 0.028 for monoclinic, and the β-angle clearly differs from 90° by 77 standard
uncertainties. This has been confirmed using several different crystals, on two
diffractometers with different radiations, and persists over a range of temperatures from 90
K to at least 220 K. Thus, we believe that the lower symmetry is correct, although both P21
and P212121 models lead to the same conclusions about the identity of the compounds, the
mix of epimers, and the absolute configuration.
Radioligand-Binding Assays
Radioligand-binding assays at human cloned GPCRs, and transporters were performed by
using the resources of the NIMH-PDSP at the University of North Carolina at Chapel Hill.
Detailed on-line protocols are available for all assays at the NIMH-PDSP web site
(http://pdsp.med.unc.edu/pdspw/binding.php). Initial screening assays were performed by
using 10 µM of isolated compounds for quadruplicate determinations, and the percent
inhibition of specific bindings were determined. Where10 µM test compounds inhibited
more than 50% of specific binding, their affinities (Ki) were further performed by using six
concentrations of unlabeled ligand spanning a 10,000-fold dose range. Ki values were
calculated by using GRAPHPAD PRIZM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Selected HMBC (arrows point from protons to carbons) and NOE correlations of
compounds 1/2
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ORTEP drawing of the two independent molecules of compounds 1/2, with 50% ellipsoids.
In each case, the O atom represented by the open ellipse is the minor component at the
disordered site.
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Selected HMBC (arrows point from protons to carbons) correlations of compounds 3/4 and
7/8
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Selected NOE correlations of compounds 3/4, 5/6, 7/8 and 9/10
Li et al. Page 13














Li et al. Page 14
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































J Nat Prod. Author manuscript; available in PMC 2013 April 27.
